These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15667976

  • 1. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
    Schuuring J, Bussink J, Bernsen HJ, Peeters W, van Der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):529-34. PubMed ID: 15667976
    [Abstract] [Full Text] [Related]

  • 2. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 3. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B.
    Cancer Chemother Pharmacol; 2005 Dec 01; 56(6):569-77. PubMed ID: 16001166
    [Abstract] [Full Text] [Related]

  • 4. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
    Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1220-32. PubMed ID: 15519795
    [Abstract] [Full Text] [Related]

  • 5. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE.
    Strahlenther Onkol; 2006 Jul 15; 182(7):400-7. PubMed ID: 16826359
    [Abstract] [Full Text] [Related]

  • 6. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):888-96. PubMed ID: 17293239
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy.
    Ansiaux R, Baudelet C, Jordan BF, Crokart N, Martinive P, DeWever J, Grégoire V, Feron O, Gallez B.
    Cancer Res; 2006 Oct 01; 66(19):9698-704. PubMed ID: 17018628
    [Abstract] [Full Text] [Related]

  • 9. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA, Krause M, Zyromska A, Lambin P, Baumann M, Wouters BG.
    Radiother Oncol; 2007 Jan 01; 82(1):96-104. PubMed ID: 17161482
    [Abstract] [Full Text] [Related]

  • 10. Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.
    Stüben G, Thews O, Pöttgen C, Knühmann K, Sack H, Stuschke M, Vaupel P.
    Strahlenther Onkol; 2003 Sep 01; 179(9):620-5. PubMed ID: 14628128
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.
    Kozin SV, Boucher Y, Hicklin DJ, Bohlen P, Jain RK, Suit HD.
    Cancer Res; 2001 Jan 01; 61(1):39-44. PubMed ID: 11196192
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U, Fillbrandt R, Westphal M.
    Clin Cancer Res; 2005 Jul 01; 11(13):4934-40. PubMed ID: 16000592
    [Abstract] [Full Text] [Related]

  • 13. Effect of carbogen breathing on the radiation response of a human glioblastoma xenograft: analysis of hypoxia and vascular parameters of regrowing tumors.
    Schuuring J, Bussink J, Bernsen HJ, Peeters W, van der Kogel AJ.
    Strahlenther Onkol; 2006 Jul 01; 182(7):408-14. PubMed ID: 16826360
    [Abstract] [Full Text] [Related]

  • 14. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
    Sun LQ, Li YX, Guillou L, Coucke PA.
    Cancer Res; 1998 Dec 01; 58(23):5411-7. PubMed ID: 9850073
    [Abstract] [Full Text] [Related]

  • 15. Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor.
    Schuck A, Poremba C, Lanvers C, Könemann S, Schleifer T, Wai D, Horn K, Hesselmann S, Braun Y, Frodermann B, Schäfer KL, Diallo RI, Rübe CE, Rübe C, Dockhorn-Dworniczak B, Willich N.
    Strahlenther Onkol; 2002 Dec 01; 178(12):701-8. PubMed ID: 12491058
    [Abstract] [Full Text] [Related]

  • 16. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
    Ning S, Laird D, Cherrington JM, Knox SJ.
    Radiat Res; 2002 Jan 01; 157(1):45-51. PubMed ID: 11754641
    [Abstract] [Full Text] [Related]

  • 17. Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice.
    Yamada S, Bu XY, Khankaldyyan V, Gonzales-Gomez I, McComb JG, Laug WE.
    Neurosurgery; 2006 Dec 01; 59(6):1304-12; discussion 1312. PubMed ID: 17277694
    [Abstract] [Full Text] [Related]

  • 18. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A, Bush T, Saffran D, Kaufman S, Belmontes B, Rex K, Hughes P, Caenepeel S, Rottman JB, Tasker A, Patel V, Kendall R, Radinsky R, Polverino A.
    Clin Cancer Res; 2009 Jan 01; 15(1):110-8. PubMed ID: 19118038
    [Abstract] [Full Text] [Related]

  • 19. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
    Huang P, Allam A, Perez LA, Taghian A, Freeman J, Suit HD.
    Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):93-8. PubMed ID: 7721643
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
    Davis DW, Takamori R, Raut CP, Xiong HQ, Herbst RS, Stadler WM, Heymach JV, Demetri GD, Rashid A, Shen Y, Wen S, Abbruzzese JL, McConkey DJ.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):678-89. PubMed ID: 15701856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.